Table 1.
Characteristic | Corticosteroid Group (N=197) | Placebo Group (N=188) |
---|---|---|
No. of children (percent) | ||
Age at entry, months | ||
2–23 | 145 (73.6) | 132 (70.2) |
24–71 | 52 (26.4) | 56 (29.8) |
Sex | ||
Maleb | 14 (7.1) | 17 (9.0) |
Female | 183 (92.9) | 171 (91.0) |
Race | ||
Caucasian | 128 (65.0) | 126 (67.0) |
African American | 41 (20.8) | 28 (14.9) |
Other/multiracial | 28 (14.2) | 34 (18.1) |
Health insurance status | ||
Private | 81 (41.1) | 97 (51.6) |
Medicaid | 108 (54.8) | 86 (45.7) |
None | 6 (3.0) | 3 (1.6) |
Unknown | 2 (1.0) | 2 (1.1) |
Fever duration before diagnosis | ||
<48 hours | 110 (55.8) | 96 (51.1) |
≥48 hours | 87 (44.2) | 92 (48.9) |
No significant differences noted between the two treatment groups except for mean age (17.2 months vs. 20.8 months in the corticosteroid and placebo groups, respectively, p=0.046).
13 of 31 (42.0%) of included males were circumcised